Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Shortage reports
Actual shortage:
61 (5%)
Anticipated shortage:
0 (0%)
Avoided shortage:
36 (3%)
Resolved:
1223 (93%)
1320
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
283 (99%)
Reversed:
2 (1%)
287
211 (13%)
35 (56%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-LOSARTAN | 100MG | TABLET | Resolved | 2021-10-18 | 2022-02-28 | 147504 |
| PMS-LOSARTAN | 50MG | TABLET | Resolved | 2021-10-18 | 2022-02-10 | 147507 |
| PMS-LOSARTAN | 50MG | TABLET | Resolved | 2023-10-30 | 2023-12-22 | 208567 |
| PMS-LOSARTAN | 100MG | TABLET | Resolved | 2023-10-30 | 2024-01-22 | 208572 |
| PMS-LOSARTAN | 25MG | TABLET | Resolved | 2023-12-27 | 2024-07-10 | 214340 |
| PMS-LOSARTAN | 100MG | TABLET | Resolved | 2018-11-29 | 2020-11-05 | 67931 |
| PMS-LOSARTAN | 25MG | TABLET | Resolved | 2018-11-29 | 2021-01-19 | 67934 |
| PMS-LOSARTAN | 50MG | TABLET | Resolved | 2019-03-04 | 2020-11-05 | 77487 |
| PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2018-11-29 | 2019-06-29 | 67937 |
| PMS-LOSARTAN-HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-11-29 | 2019-06-11 | 67940 |
| PMS-LOSARTAN-HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-07-31 | 2020-05-19 | 90473 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-08-01 | 2020-05-19 | 90536 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2019-09-12 | 2020-05-19 | 93816 |
| PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2019-09-12 | 2020-02-04 | 93819 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-11-17 | 2018-02-22 | 29509 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-02-06 | 2018-04-19 | 38917 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2018-05-18 | 2019-06-29 | 49747 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-09-19 | 2017-11-17 | 22782 |
| PMS-LOSARTAN-HCTZ | 12.5MG 100MG | TABLET | Resolved | 2017-09-19 | 2017-10-11 | 22785 |
| PMS-LOSARTAN-HCTZ | 25MG 100MG | TABLET | Resolved | 2021-11-15 | 2022-01-26 | 149230 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4993 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4990 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| ACET CODEINE 30 | 300MG 30MG | TABLET | Discontinued | 2018-02-22 | 2018-07-23 | 40586 |
| ACET CODEINE 60 | 300MG 60MG | TABLET | Discontinued | 2019-01-16 | 2019-01-17 | 72608 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 15MG 8MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117751 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 8MG 15MG 300MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117748 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25692 |
| ACETAMINOPHEN, CAFFEINE & CODEINE | 300MG 8MG 15MG | TABLET | Discontinued | 2017-10-12 | 2017-10-13 | 25698 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137982 |
| ATORVASTATIN | 10MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137986 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137995 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137992 |
| ATORVASTATIN | 40MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137998 |
| ATORVASTATIN | 80MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 138001 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2021-04-23 | 2021-04-23 | 137989 |
| ATORVASTATIN | 20MG | TABLET | Discontinued | 2020-07-23 | 2020-07-23 | 120976 |
| CHARCODOTE SUSP 200MG/ML | 200MG | SUSPENSION | Discontinued | 2020-06-16 | 2020-06-16 | 118017 |
| EGOZINC-HC | 0.5% 0.5% | OINTMENT | Discontinued | 2020-06-15 | 2021-10-27 | 117754 |